FDA Approves First Drug to Delay Onset of Type 1 Diabetes
FRIDAY, Nov. 18, 2022 -- The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D).
Teplizumab (Tzield) targets the autoimmune issues that drive the disease, rather than its...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Autoimmune Disease | Diabetes | Diabetes Type 1 | Endocrinology | Food and Drug Administration (FDA) | General Medicine